-Dow Jones
Catalent Plans $100M Expansion Of Biologics Capabilities At Italian Vaccine Plant
Catalent Inc (NYSE: CTLT) will begin the first phase of a planned $100 million expansion at its facility in Anagni, Italy,
Related Posts
Morgan Stanley Maintains Equal-Weight on Sempra Energy, Lowers Price Target to $155
Morgan Stanley analyst Stephen Byrd maintains Sempra Energy (NYSE:SRE) with a Equal-Weight and lowers the price target from $158 to $155.
Tesla Launches Full Self Driving Subscription Package At $199 Per Month, Aims To Deliver Level 5 Full Self-Driving System
On Saturday, Elon Musk’s Tesla Inc (NASDAQ:TSLA) launched its Full Self-Driving (FSD) subscription for its driver-assistance software package for $199…
Babcock & Wilcox Renewable Receives $38M Technology Award For New Waste-To-Energy Facilities In East Asia
Babcock & Wilcox (B&W) (NYSE:BW) announced today that its B&W Renewable segment has received an award for more than $38 million to supply waste-to-energy technologies for municipal waste projects in East